Equities research analysts expect Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) to report earnings of ($0.05) per share for the current quarter, according to Zacks. Three analysts have made estimates for Tabula Rasa Healthcare’s earnings, with the lowest EPS estimate coming in at ($0.07) and the highest estimate coming in at ($0.03). The business is expected to issue its next quarterly earnings results on Monday, August 7th.

On average, analysts expect that Tabula Rasa Healthcare will report full-year earnings of $0.11 per share for the current year, with EPS estimates ranging from $0.07 to $0.16. For the next financial year, analysts expect that the company will report earnings of $0.46 per share, with EPS estimates ranging from $0.41 to $0.50. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that that provide coverage for Tabula Rasa Healthcare.

Tabula Rasa Healthcare (NASDAQ:TRHC) last posted its earnings results on Monday, May 1st. The company reported $0.04 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.06 by $0.02. The business had revenue of $27.70 million for the quarter, compared to the consensus estimate of $26 million. The company’s revenue for the quarter was up 37.1% compared to the same quarter last year.

Several brokerages recently issued reports on TRHC. Zacks Investment Research lowered shares of Tabula Rasa Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, March 16th. Stifel Nicolaus cut their target price on shares of Tabula Rasa Healthcare from $19.00 to $16.00 and set a “buy” rating on the stock in a research note on Tuesday, May 2nd. Finally, Piper Jaffray Companies increased their target price on shares of Tabula Rasa Healthcare from $18.00 to $19.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 14th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Tabula Rasa Healthcare has a consensus rating of “Buy” and a consensus price target of $16.75.

In related news, Director Glen R. Bressner bought 7,500 shares of the business’s stock in a transaction that occurred on Thursday, May 18th. The shares were acquired at an average cost of $11.96 per share, with a total value of $89,700.00. Following the completion of the purchase, the director now directly owns 18,256 shares in the company, valued at $218,341.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Orsula V. Knowlton sold 8,000 shares of the stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $11.94, for a total transaction of $95,520.00. Following the transaction, the insider now directly owns 919,407 shares in the company, valued at $10,977,719.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 38,759 shares of company stock worth $520,844. 45.80% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. TIAA CREF Investment Management LLC raised its position in shares of Tabula Rasa Healthcare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock valued at $110,000 after buying an additional 4,232 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Tabula Rasa Healthcare during the first quarter valued at about $178,000. Russell Investments Group Ltd. bought a new position in shares of Tabula Rasa Healthcare during the fourth quarter valued at about $875,000. Hood River Capital Management LLC raised its position in shares of Tabula Rasa Healthcare by 30.1% in the first quarter. Hood River Capital Management LLC now owns 767,501 shares of the company’s stock valued at $10,346,000 after buying an additional 177,774 shares in the last quarter. Finally, Wellington Management Group LLP increased its position in Tabula Rasa Healthcare by 37.2% in the first quarter. Wellington Management Group LLP now owns 782,142 shares of the company’s stock valued at $10,544,000 after buying an additional 212,164 shares during the last quarter. 24.93% of the stock is currently owned by institutional investors and hedge funds.

Shares of Tabula Rasa Healthcare (TRHC) opened at 15.53 on Friday. The firm’s market capitalization is $267.40 million. Tabula Rasa Healthcare has a one year low of $10.39 and a one year high of $16.85. The company’s 50 day moving average is $13.64 and its 200-day moving average is $13.91.

TRADEMARK VIOLATION WARNING: “Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) Expected to Announce Earnings of -$0.05 Per Share” was reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2017/07/07/tabula-rasa-healthcare-inc-nasdaqtrhc-expected-to-announce-earnings-of-0-05-per-share.html.

About Tabula Rasa Healthcare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Get a free copy of the Zacks research report on Tabula Rasa Healthcare (TRHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.